Editorial: Enabling Technologies Advance Poorly Soluble Highly Potent APIs

Regulatory Requirements for Early Phase Drug Product Development

Editorial: Designing a CMC Strategy for Accelerated Development of Biotherapeutics

Editorial: Novel Therapies Roundtable Discussion


Alcami Pays Tribute to Fallen Patriots this Memorial Day

Alcami Exhibiting at BIO International Convention 2019

Alcami Supports Homestead High School’s Varsity Robotics Club

Stability: Top Testing Factors You Should Consider

Alcami and Students 2 Science Inspire Future Scientists


Alcami St. Louis Facility Issued European Medicines Agency Certification

Editorial: Overcoming the Opioid Overdose Crisis

Alcami Celebrates Earth Day with Community Cleanups

Crystallization in Solid State Chemistry

White Paper: Structural Characterization of Biologics Using High-Resolution Mass Spectrometry

Understanding Biologics: Your Top 7 Questions Answered

Video: Extractables and Leachables

The 6 Pillars of Solid State Chemistry


eBook: Elemental Impurities

ON-DEMAND WEBINAR: The Importance of Microbial In-Use Studies

Alcami Exhibiting and Presenting at CPhI North America

Editorial: An Interview with Alcami

ON-DEMAND ALCAMI MASTER CLASS WEBINAR: Early Phase Development of Biologics

Alcami Kickstarts Biologics Enterprise to Advance Treatments for Complex Medical Conditions

Editorial: Oral Solids Endure & Evolve

Editorial: HPAPIs - A CDMO View

Connect Faster: Introducing Alcami RightNow™

Editorial: Fuelling Pharma's Innovation Engines


Beyond the Bench: UNC Wilmington Classroom to cGMP Laboratories

Staying Ahead of OSD Challenges

Alcami Attending DCAT Week 2019


Editorial: Outsourcing Analytical Testing - The Gateway to Drug Manufacturing

Editorial: A Practical Approach to Extractables & Leachables

The Top Five Most Asked Extractables and Leachables Questions Answered


Video: Alcami's Oral Solid Dose Manufacturing

PART II: HPAPI Market Forecasts and Manufacturing Challenges

Agency-Accepted Testing and Filing Strategy for Elemental Impurities


Alcami STEAM Outreach Efforts Aim to Inspire Students, Advance Workforce

PART I: HPAPI Market Forecasts and Manufacturing Challenges

Case Study: Medicines Development for Global Health

The Top Eight Most Asked Questions about Microbial In-Use Studies

White Paper: Insight into Orphan Drug Formulations and Regulations

Alcami Employee Recognized with Honor Flight

Alcami President & CEO Elected as 1st Vice President of the Board of Directors of the Drug, Chemical & Associated Technologies Association

Beyond the Label: Four Challenges to Serialization

ON-DEMAND WEBINAR: Submitting Samples through Alcami OnDemand™


Important Steps for Quota, Import, and Export Processes for DEA Controlled Substances

Alcami Launches New Features and Enhancements to Alcami OnDemand

Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

Editorial: Aligning with Sponsors for Strategic Growth

Case Study: Stability When You Need it Most


ON-DEMAND WEBINAR: Extractables & Leachables 101: The Past, Present, and Future

Alcami and UNCW Awarded Biomanufacturing Workforce Development Grant


White Paper: Optimizing HPAPI Manufacturing Performance

Formulating for Orphan Indication Drug Products

White Paper: A Practical Approach to Extractables and Leachables on Manufacturing Surfaces

Alcami Presenting and Exhibiting at CPhI Worldwide, 9 - 11 October 2018 in Madrid, Spain

Successful Methods for Obtaining Orphan Drug Approval

Alcami Attending 58th Annual Pharmaceutical Analysis Conference


ON-DEMAND WEBINAR: Balancing HPAPI Control with the Chemistry and Efficiency Needs of a CDMO

Considerations for Abuse-Deterrent Category One Syringeability Studies

The Role of Full Time Equivalent (FTE) Programs

Alcami Renews Partnership with Wisconsin Department of Natural Resources to Revitalize State Trails

eBook: Guide to Stability

ON-DEMAND WEBINAR: Successful Application of the New Elemental Impurities Regulation


Editorial: High-Resolution Mass Spectrometry - A Map to Biologics

Editorial: The role of DoE in early phase development

Alcami Presenting and Exhibiting at Biotech Outsourcing Strategies 2018

Alcami Announces Donation to Wilmington, North Carolina Fire Department

Alcami’s Extended Workbench Supports Commercial Supply of Flexion Therapeutics’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

Alcami Presenting and Exhibiting at 7th Annual HPAPI Summit

Case Study: Implementing Serialization

Alcami Presenting and Exhibiting at Chemspec Europe 2018

Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners


Alcami Presenting and Exhibiting at PharmaTalk

Open House: Join Us at Our Wilmington, NC Site

Beyond the Bench: A Century of Experience

Alcami Exhibiting at BIO International Convention 2018

Elevate Product Stewardship and Exceed Your Sustainability Goals

Alcami Announces Industry-Leading Analytical Testing Turnaround Time

Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

Case Study: Orphan Drug Product


Top 7 Benefits of the Bruker D8 DISCOVERY HTS™

Understanding Pharmaceutical Packaging

ON-DEMAND WEBINAR: Quoting and Sample Submission. Made Simple.

Alcami Exhibiting at CPhI North America

Editorial: Pharma CEO Talks Company Growth, Jobs with New Triangle HQ

Alcami Exhibiting and Presenting at Interphex 2018


Panel Discussion: Oral Solid Dosage Manufacturing Process 

Editorial: Driving Change in the Pharma Industry and Biotech One Relationship at a Time

Editorial: Is Industry Ready for the Serialisation Shake-Up?

Alcami Donation to Outfit TROSA Medical Department

Editorial: Transparent and Timely Testing

Alcami Supports STEM Education at Local High School


Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

Serialization CDMO Checklist

ON-DEMAND WEBINAR: Elemental Impurities - Missed the Deadline? Now What?

Editorial: Stability Testing Ensures Proper Packaging for Drug Storage

Editorial: Tackling the Opioid Crisis with Abuse-Deterrent Formulations

Stability: Back to the Basics - Part V


Alcami Attending DCAT Week '18

Beyond the Bench: Analytical Development and Professional Growth

Editorial: Analytical Testing - Contractors Take on the Challenge of Complex Molecules

ON-DEMAND WEBINAR: Accelerating Drug Development through Automation


Stability: Back to the Basics - Part IV

Alcami Helps Fight Opioid Addiction Epidemic


ON-DEMAND WEBINAR: Abuse-Deterrent Category One Testing: Syringeability Studies

Alcami Furthers Expansion with New West Coast Sales Office

Stability: Back to the Basics - Part III

Alcami Awarded Prosperity Prize at Business Ready Wisconsin Conference

Abuse-Deterrent Studies – An Interview with Angela Moore

Alcami Announces Manufacturing Agreement for Solasia’s Active Pharmaceutical Ingredient Darinaparsin

Alcami Presenting and Exhibiting at 2017 AAPS Annual Meeting and Exposition

Alcami Expands Presence on DCAT's Board of Directors and Advisory Council

Editorial: Right-First-Time Innovation Approach Drives Continual Investment

Filter Validation – An Interview with Stacey Ramsey

ON-DEMAND WEBINAR: Elemental Impurities Q&A - Ask Our Experts

Alcami Wins Prestigious Business of the Year Award from St. Louis Mayor


Alcami Establishes International Sales Office in Japan

8 Characteristics of a State-of-the-Art Highly Potent API Facility

Alcami Technical Evaluations Specialist Speaks at University of Wisconsin-Washington County STEM Club

Stability: Back to the Basics - Part II

ON-DEMAND WEBINAR: Approach to HPAPI Suite Design in a Multi-Use Facility

Join us in Cambridge, MA on Thursday, October 19th!

Open House: Join Us at Our Edison, NJ Site

Have a Highly Potent API? Here's What You Need to Consider


Editorial: Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations

White Paper: 4 Factors Critical to the Financial Success of an Emerging Pharmaceutical Company

Alcami Presenting and Exhibiting at CPhI Worldwide, October 24-26, 2017 in Frankfurt, Germany

Minimize Supply Disruption at Any Life Cycle Phase

Stability: Back to the Basics - Part I

At-A-Glance: Highly Potent API

Alcami Announces Grand Opening of St. Louis, Missouri Facility in Cortex Innovation Community

Track Your Project with Alcami OnDemand™

How Risk Assessment and Planning Safeguard a Supply Chain

Alcami to Establish Active Pharmaceutical Ingredient Center of Excellence in Germantown, Wisconsin

Identifying and Reducing Risks within the Pharmaceutical Supply Chain

Framework to Biologics – Part Three

How to Run a Successful Clinical Study the First Time - Part Two


Executive Voice: Leading a Shift from Wilmington to RTP

How to Run a Successful Clinical Study the First Time - Part One

Framework to Biologics – Part Two

Pitfalls of a Non-Integrated Drug Development Process

Framework to Biologics – A Three Part Series

ON-DEMAND WEBINAR: The Future State of Supply Chain Solutions

Open House: Join Us at Our New St. Louis, MO Site

Alcami Exhibiting at 57th Annual Land O' Lakes Pharmaceutical Analysis Conference


Alcami Corporation and the University of North Carolina Wilmington Announce Academic Partnership

ON-DEMAND WEBINAR: Elemental Impurities - A Deep Dive into Potential Contamination Sources

Video: Charleston Regional Development Alliance Features Alcami

Alcami Announces Transition of Global Headquarters to Research Triangle Park (RTP) in North Carolina

Editorial: Oral Solid Dosage Manufacturing Roundtable

Editorial: Implications of Serialization for the U.S. Pharma Industry

Alcami Awarded for 2016 Manufacturing and Laboratories Operations Performance


Interview: Alcami CEO Featured in Special Report on United States’ Biopharmaceutical Industry 2017

Alcami Partners with Wisconsin Department of Natural Resources to Rebuild Kettle Moraine State Forest Trail

Alcami Exhibiting at BIO International 2017

Alcami Exhibiting and Presenting at the 6th Annual HPAPI Summit

In-Use Stability Testing: Providing the Right Instructions


Serialization - Data Management Challenges

White Paper: Guide to Pharmaceutical Serialization 2017

Limited Lab Capacity? An Extended Workbench Program can help

Alcami Participates in Wings for Life Run 2017

FAQs on What Happens If You Miss the Serialization Deadline

Alcami Participates in WILMA Dash and Health Fest

ON-DEMAND WEBINAR: Get on Track with Serialization - Lessons Learned

St. Louis Relocation Newsletter #3

Extractables and Leachables – Why?

Serialization Overview: What’s Required for November 27, 2017 Deadline

Alcami Exhibiting at CPhI North America and InformEx, May 16 - 18, 2017

Alcami Participating in Upcoming STEAM Train Express

Bringing the Light to Photostability in Three Parts - Part Three

Video: The Alcami Experience - An Interview with Pharmaceutical Technology Magazine

White Paper: Extractables and Leachables Testing in the Pharmaceutical Industry


Alcami Presenting at the 2017 Laboratory Design Conference

Alcami Attending AAPS National Biotechnology Conference 2017

Bringing the Light to Photostability in Three Parts - Part Two

Alcami Announces Extended Workbench Offering for Analytical Services

Editorial: Formulation Development & Manufacturing — CDMOs Offer Speed, Advanced Technologies, & the Ability to Handle More Potent APIs

Alcami Exhibiting and Presenting at CPhI Japan April 19 - 21, 2017

Bringing the Light to Photostability in Three Parts

Elemental Impurities – Highlights of the Coming Regulation

ON-DEMAND WEBINAR: Elemental Impurities - Everything You Need to Know

ON-DEMAND WEBINAR: Critical Drug Substance Considerations for Formulation Success in Drug Product Development

Editorial: Alcami Featured in Pharma Horizon's January 2017 Issue

Alcami Introduces Seamless Customer Experience with New Customer Portal and Application, Alcami OnDemand™


Executive Q&A: Keys to Cultural Integration

Editorial: Supporting the Pharma Industry Small Business Growth Engine

Alcami Attending DCAT Week '17

Alcami in Action: 2016 in Review

Alcami Invests in Bruker’s D8 DISCOVER HTS™ System for High-Throughput X-Ray Diffraction Screening in Pharmaceutical Formulation Development

Executive Brief: An Opioid Abuse-Deterrent Roadmap for the Pharmaceutical Industry

Antibiotic Potency Testing: The Methods - Part 2

White Paper: Abuse-Deterrent Studies for Controlled Drugs - A Changing Landscape

Antibiotic Potency Testing: The Methods – Part 1


Editorial: The Future of Pharma - Embracing a Changing Landscape

Need to Know: Details About Alcami's New St. Louis, MO Facility

Elemental Impurities: The Risk-Based Approach

Alcami Donates Life-Saving LUCAS® 3 Chest Compression System to Germantown, WI Fire Department

ON-DEMAND WEBINAR: Demonstrate Abuse-Deterrent Properties in Opioid Formulations

Overview and Performance of the Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics

Battling the Opioid Abuse Epidemic - Top 10 Important Guidances and Resources

The Effect of Abuse-Deterrent Formulations on Opioid Abuse

Alcami Presenting at Nice Symposium 2017 Oral Solid Dose

Elemental Impurities: Updated Regulatory Requirements

Editorial: Analytical Testing: Market Drivers, Growing Demand & Client Needs

Have you Heard? Alcami’s St. Louis, MO Site is Moving!

WEBINAR: Critical Drug Substance Considerations for Formulation Success in Drug Product Development

Serialization and Track and Trace

Editorial: Supply Chain Management and the Importance of Security of Supply

Dr. Stephan Kutzer, Alcami CEO & President, Appointed to DCAT Board of Directors

WEBINAR: How to Submit a Sample Using Alcami’s Enhanced Online Sample Submission Process

Alcami Presenting at the 3rd Human Abuse Liability & Abuse –Deterrent Formulations Conference

Alcami Presenting and Exhibiting at the AAPS Annual Meeting and Exposition to be Held November 13-17, 2016 in Denver, CO

Alcami Announces Innovative Protect Your Brand™ Offering to Secure Your Supply Chain

Alcami Announces Enhanced Analytical Services in Edison, New Jersey

Join Us on September 22nd at our Edison, NJ Facility

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

Alcami Presenting and Exhibiting at CPhI Worldwide 2016, October 4-6, 2016 in Barcelona

Contract Pharma, September 22nd - 23rd

Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities

Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI

St. Louis Relocation Newsletter

St. Louis Relocation Regulatory Change Notification

Alcami Sponsors Employee Engagement Day at Students 2 Science

Quality and Regulatory Affairs Notification Letter

Alcami Announces Enhanced Laboratory Services in Wilmington, NC Headquarters

Alcami Invests in MicroSEQ® Rapid Microbial Identification System to Expand its Service Capabilities at Four U.S. Sites

Join Us on May 19th at our Durham, NC facility

AAPS National Biotechnology Conference, May 16-18

Interphex, April 26th - 28th

Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

CphI Japan 2016, April 20th - 22nd

BioEurope Spring 2016, April 4th - 6th

AAI Pharma Services Corporation And Cambridge Major Laboratories, Inc. Are Now Alcami

Strengthening CDMOs to Meet Industry Needs For 2016 And Beyond

Feature in Manufacturing Chemist Pharma - Setting The Course For Success

DCAT 2016, March 14th - 17th

2016 PDA Annual Meeting, March 14th - 16th

Investment of $10.7M in New Facility at Cortex Innovation Center in St. Louis, MO

Expanding Capabilities and Capacity for Sterile Drug Product Manufacturing in Charleston, SC

ProForm Select™ Integrated Offering for Solid State Chemistry and Formulation Development

Additional Equipment and Capacity for Drug Product Manufacturing in Wilmington, NC

New Investment in DE Dietrich Agitated Filter Dryer To Improve its Manufacturing Capabilities in Weert, The Netherlands

Investment of $15M in Additional Laboratory Capacity and Global Headquarters in Wilmington, NC

Bolstering Capabilities For Parenteral Drug Development and Manufacturing

Expanding Disinfectant Effectiveness/Qualification Services in St. Louis, MO

Freeslate Powder Dispensing System Is Selected To Increase Solid State Capabilities

Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For Atossa’s Lead Drug Candidate Afimoxifene Gel

Announcing the Appointments of Ted Dolan as Vice President, API Operations and Syed T. Husain as Vice President, API Business Unit

Marcel Schreuder Goedheijt appointed General Manager of Cambridge Major Laboratories – Europe

Announcing Stephan Kutzer as Chief Executive Officer